Section Arrow
CSTL.NASDAQ
- Castle Biosciences
Quotes are at least 15-min delayed:2026/09/01 22:26 EDT
Regular Hours
Last
 33.44
+0.41 (+1.24%)
Day High 
34.09 
Prev. Close
33.03 
1-M High
35.2 
Volume 
396.18K 
Bid
22
Ask
33.53
Day Low
32.89 
Open
33 
1-M Low
27.83 
Market Cap 
1.01B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 33.18 
20-SMA 32.1 
50-SMA 27.42 
52-W High 44.28 
52-W Low 17.722 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.64/-0.68
Enterprise Value
1.04B
Balance Sheet
Book Value Per Share
15.39
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
344.23M
Operating Revenue Per Share
6.29
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BIAFbioAffinity Technologies Inc6.59+2.03+44.52%-- 
PSNLPersonalis17.06+0.28+1.67%-- 
DHRDanaher Corp206.93-6.63-3.10%38.07PE
RVTYRevvity126.59-2.08-1.62%61.86PE
OPKOPKO Health1.52+0.05+3.40%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.